Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125,404 | -293,423 | -9,756 | -7,012 | -3,753 |
| Depreciation Amortization | -137 | 5 | 4 | 3 | 1 |
| Accounts payable and accrued liabilities | 1,465 | -1,059 | -784 | -711 | -968 |
| Other Working Capital | 2,043 | -632 | -147 | 299 | -618 |
| Other Operating Activity | 116,606 | 281,598 | 1,652 | 1,307 | 1,265 |
| Operating Cash Flow | $-5,427 | $-13,511 | $-9,030 | $-6,114 | $-4,072 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -45,294 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-45,294 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,200 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -121 | 74,451 | -45 | 0 | 0 |
| Financing Cash Flow | $1,079 | $74,451 | $-45 | $N/A | $N/A |
| Beginning Cash Position | 82,402 | 21,462 | 21,462 | 21,462 | 21,462 |
| End Cash Position | 32,760 | 82,402 | 12,387 | 15,348 | 17,390 |
| Net Cash Flow | $-49,642 | $60,940 | $-9,075 | $-6,114 | $-4,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,427 | -13,511 | -9,030 | -6,114 | -4,072 |
| Free Cash Flow | -5,427 | -13,511 | -9,030 | -6,114 | -4,072 |